User contributions
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
- 12:31, 12 June 2019 (diff | hist) . . (-1,046) . . DEC1
- 09:19, 12 June 2019 (diff | hist) . . (-20) . . DEC1
- 09:17, 12 June 2019 (diff | hist) . . (+215) . . DEC1
- 09:10, 12 June 2019 (diff | hist) . . (+3,280) . . N DEC1 (Created page with "''DEC1'', an antinsense transcript required for tumorogenicity of ovarian and colorectal cancer cells ==Annotated Information== ===Name=== ''DEC1': deleted in esophageal canc...")
- 03:31, 26 December 2018 (diff | hist) . . (+2,966) . . N LINC01703 (Created page with "''LINC01703'', regulates the expression of PARP1 and is a novel molecule involved in the progression of HCC ==Annotated Information== ===Approved Symbol=== ''LINC01703'' ===A...")
- 03:10, 26 December 2018 (diff | hist) . . (+59) . . ZSCAN2-DT (current)
- 03:09, 26 December 2018 (diff | hist) . . (+42) . . ZSCAN2-DT (→Approved Name)
- 03:02, 26 December 2018 (diff | hist) . . (+1,486) . . N ZSCAN2-DT (Created page with "''ZKSCAN2-DT'', ==Annotated Information== ===Approved Symbol=== ''ZKSCAN2-DT'' ===Approved Name=== ''ZKSCAN2-DT'': ===Characteristics=== ''ZKSCAN2-DT'' is a long noncoding...")
- 02:45, 26 December 2018 (diff | hist) . . (+2,143) . . N ZKSCAN7-AS1 (Created page with "''ZKSCAN7-AS1'', a set of biomarkers for the prognosis of patients with GBM,enabling a moreaccurate prediction of survival and revealingmorebiological functions. ==Annotated...")
- 02:38, 26 December 2018 (diff | hist) . . (+2,497) . . N LINC02601 (Created page with "''LINCO2601'', a set of biomarkers for the prognosis of patients with GBM,enabling a moreaccurate prediction of survival and revealingmorebiological functions. ==Annotated In...") (current)
- 02:25, 26 December 2018 (diff | hist) . . (+2,107) . . N ITGA6-AS1 (Created page with "''ITGA6-AS1'', a set of biomarkers for the prognosis of patients with GBM,enabling a moreaccurate prediction of survival and revealingmorebiological functions. ==Annotated In...")
- 02:18, 26 December 2018 (diff | hist) . . (+17) . . ACTR3-AS1 (→Sequence)
- 02:18, 26 December 2018 (diff | hist) . . (+2,169) . . N ACTR3-AS1 (Created page with "''ACTR3-AS1'', a set of biomarkers for the prognosis of patients with GBM,enabling a moreaccurate prediction of survival and revealingmorebiological functions. ==Annotated In...")
- 07:06, 25 December 2018 (diff | hist) . . (+97) . . MPPED2-AS1 (current)
- 07:04, 25 December 2018 (diff | hist) . . (+6,384) . . N MPPED2-AS1 (Created page with "''MPPED2-AS1'', and its associated gene MPPED2 are down-regulated in Human Thyroid Neoplasias and act as tumour suppressors ==Annotated Information== ===Approved Symbol=== '...")
- 06:27, 24 December 2018 (diff | hist) . . (+68) . . ARLNC1
- 06:24, 24 December 2018 (diff | hist) . . (+4,417) . . N ARLNC1 (Created page with "''ARLNC1'', plays an important role in prostate cancer progression ==Annotated Information== ===Approved Symbol=== ''ARLNC1'' ===Approved Name=== ''ARLNC1'': ===Characterist...")
- 05:52, 24 December 2018 (diff | hist) . . (+3,136) . . N LINC01121 (Created page with "''LINC01121'', Inhibits Cell Apoptosis While Facilitating Proliferation, Migration, and Invasion Though Negative Regulation of the Camp/PKA Signaling Pathway via GLP1R ==Anno...")
- 03:15, 24 December 2018 (diff | hist) . . (+4,085) . . N NGF-AS1 (Created page with "''NGF-AS1'', is a SNP containing long noncoding RNA associated with Dysmenorrhea. ==Annotated Information== ===Approved Symbol=== ''NGF-AS1'' ===Approved Name=== ''NGF-AS1'':...") (current)
- 02:35, 24 December 2018 (diff | hist) . . (+8,320) . . N NKAIN3-IT1 (Created page with "''NKAIN3-IT1'', is dysregulated in Glioblastoma. ==Annotated Information== ===Approved Symbol=== ''NKAIN3-IT1'' ===Approved Name=== ''NKAIN3-IT1'': NKAIN3 intronic transcript,...") (current)
(newest | oldest) View (newer 20 | older 20) (20 | 50 | 100 | 250 | 500)
